The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Core Scientific Inc (NASDAQ: CORZ) closed at $17.17 up 3.31% from its previous closing price of $16.62. In other words, the price has increased by $3.31 from its previous closing price. On the day, 12.67 million shares were traded. CORZ stock price reached its highest trading level at $17.29 during the session, while it also had its lowest trading level at $16.025.
Ratios:
For a deeper understanding of Core Scientific Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78.
On July 22, 2025, Arete started tracking the stock assigning a Buy rating and target price of $20. On May 22, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $15.Citizens JMP initiated its Mkt Outperform rating on May 22, 2025, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 25 ’25 when DUCHENE TODD M sold 7,759 shares for $12.39 per share. The transaction valued at 96,142 led to the insider holds 2,049,689 shares of the business.
DUCHENE TODD M bought 7,759 shares of CORZ for $96,142 on Jun 25 ’25. On Jun 06 ’25, another insider, Becker Todd A, who serves as the Former Director of the company, bought 195,687 shares for $12.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORZ now has a Market Capitalization of 5243863040 and an Enterprise Value of 5824977920. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.05. Its current Enterprise Value per Revenue stands at 16.718 whereas that against EBITDA is -106.704.
Stock Price History:
The Beta on a monthly basis for CORZ is 6.55, which has changed by 0.3320403 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, CORZ has reached a high of $18.63, while it has fallen to a 52-week low of $6.20. The 50-Day Moving Average of the stock is 20.09%, while the 200-Day Moving Average is calculated to be 40.35%.
Shares Statistics:
For the past three months, CORZ has traded an average of 19.89M shares per day and 15710310 over the past ten days. A total of 303.15M shares are outstanding, with a floating share count of 284.98M. Insiders hold about 6.69% of the company’s shares, while institutions hold 90.03% stake in the company. Shares short for CORZ as of 1756425600 were 56587006 with a Short Ratio of 2.85, compared to 1753920000 on 57610630. Therefore, it implies a Short% of Shares Outstanding of 56587006 and a Short% of Float of 18.69.
Earnings Estimates
The dynamic stock of Core Scientific Inc (CORZ) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.2, with high estimates of $0.2 and low estimates of $0.2.
Analysts are recommending an EPS of between $0.31 and $0.31 for the fiscal current year, implying an average EPS of $0.31. EPS for the following year is $1.76, with 1.0 analysts recommending between $1.76 and $1.76.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $119.04M this quarter.It ranges from a high estimate of $128.28M to a low estimate of $106M. As of the current estimate, Core Scientific Inc’s year-ago sales were $95.35MFor the next quarter, 7 analysts are estimating revenue of $157.89M. There is a high estimate of $179.06M for the next quarter, whereas the lowest estimate is $144.3M.
A total of 7 analysts have provided revenue estimates for CORZ’s current fiscal year. The highest revenue estimate was $445.86M, while the lowest revenue estimate was $409M, resulting in an average revenue estimate of $425.54M. In the same quarter a year ago, actual revenue was $510.67MBased on 16 analysts’ estimates, the company’s revenue will be $877.93M in the next fiscal year. The high estimate is $1.16B and the low estimate is $515.5M.
